BuddhistTCGH
Hualien City, 970473, Taiwan
Location status: Recruiting
NCT Number: NCT07230210
Sarcopenia, characterized by muscle loss and weakness, is a major health issue among older adults and impacts mobility and quality of life. This study addresses the current lack of long-term, technology-assisted support for managing this condition at home. This randomized controlled trial (RCT) will evaluate a 12-week smart-technology-based program for 60 older adults at risk of sarcopenia.
Intervention:
Participants in the intervention group will receive a technology-assisted program delivered through a Line Bot system. The platform provides personalized exercise training videos, nutrition education, daily reminders, and a point-based logging system to support adherence and monitor engagement. The control group will receive standard clinic-based care.
Purpose:
The study aims to examine whether the smart technology intervention can improve muscle mass, physical performance, quality of life, and self-management ability among older adults at risk of sarcopenia.
Expected Benefit:
The digital intervention is anticipated to offer a more effective, accessible, and sustainable approach compared with standard care, providing practical support for preventing muscle decline in community-dwelling older adults
Interested in participating?
Request Info65 year and older
All sexes
Interventional
Not applicable
Hualien City, 970473, Taiwan
Location status: Recruiting
This randomized controlled trial (RCT) is designed as a 12-week intervention to evaluate the efficacy of a smart technology-assisted nutrition and exercise program for community-dwelling older adults (aged ≥ 65 years) at risk of sarcopenia. Participants (N = 60) will be randomly assigned to either the intervention group (n = 30) or the control group (n = 30). Data will be collected at baseline, week 8 (mid-intervention), and week 12 (post-intervention).
Intervention Group:
Participants will receive the 12-week program delivered through a dedicated Line Bot platform. Core components include:
Exercise Training: Three progressive exercise videos (resistance, aerobic, and balance training) designed to enhance muscle function.
Nutrition Education: One video focusing on adequate protein intake and dietary habits essential for muscle maintenance.
Smart Technology Features: The Line Bot functions as a personalized case management tool, offering daily reminders for exercise and protein intake, an interactive calculator for estimating daily protein consumption, and a digital logging system with motivational rewards to support adherence and self-management behaviors.
Control Group:
Participants will receive standard outpatient care and general health education pamphlets. They will not receive access to the Line Bot system, exercise videos, or personalized support.
Primary outcome data will be collected at week 12. Statistical analyses will include descriptive statistics and inferential methods, such as repeated measures analysis of variance (ANOVA), to examine the effectiveness of the intervention.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Score ≥ 11 on the SARC-CalF questionnaire, indicating risk of sarcopenia.
No evident functional impairment in the limbs and able to complete handgrip strength, walking speed, and muscle mass assessments.
Possesses basic reading, writing, and calculation abilities sufficient to understand study-related materials and complete informed consent and daily logs.
Owns a smartphone and has used it for at least one year, with basic operational ability (e.g., sending and receiving LINE messages, scanning QR codes).
Exclusion criteria
Self-reported functional impairment in any limb.
Requires assistance from a wheelchair, walker, or cane for ambulation.
Has an implanted cardiac pacemaker.
Currently participating in, or planning to participate in, other physical training courses or nutrition programs during the study period.
The 12-week progressive exercise program (resistance, aerobic, and balance training) is uniquely delivered and monitored via a dedicated **Line Bot platform**. This differentiates it from traditional in-person or non-interactive video programs. The platform includes interactive features like daily reminders and a digital diary to enhance adherence and support participant self-management, aiming for five exercise sessions per week.
Time frame: Baseline (Week 0), Week 8, and Final Assessment at Week 12.
The change in skeletal muscle mass will be assessed using Appendicular Skeletal Muscle Mass (ASM), derived from bioelectrical impedance analysis (BIA). The primary endpoint is the between-group difference in the absolute change in ASM (in kilograms) from baseline to the end of the 12-week intervention (Week 12)
Contact information is provided by the study sponsor or research team.
HSIAO MEI LAN
Other
The Effectiveness of Smart Technology Interventions Combining Nutrition and Exercise for Older Adults at Risk of Sarcopenia
Acronym: S-TEN
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06329622
Atrophy, Chronic Disease
Shanghai, China
View Trial DetailsNCT07715721
Atrophy, Mental Disorders
Tainan, Taiwan
View Trial DetailsNCT07724587
Atrophy, Muscular Atrophy
Ningbo, China
View Trial DetailsNCT07500376
Atrophy, Bronchial Neoplasms
Samsun, Turkey (Türkiye)
View Trial Details